血府逐瘀汤加减联合尼可地尔治疗对冠心病心绞痛患者血栓前状态、内皮功能及心肌损伤的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4

基金项目:

浙江省中医药科技计划项目(2023ZL758)


Effect of Combination Use of Modified Xuefu Zhuyu Decoction and Nicorandil on Prethrombotic State, Endothelial Function and Myocardial Injury of Patients with Angina Pectoris of Coronary Heart Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察血府逐瘀汤加减联合尼可地尔治疗对心血瘀阻型冠心病心绞痛患者血栓前状态、内皮 功能及心肌损伤的影响。方法:选择2021年1月—2023年12月兰溪立德医院收治的86例心血瘀阻型冠心病心 绞痛患者,按照随机数字表法分为观察组、对照组各43例。对照组予尼可地尔片治疗,观察组予血府逐瘀汤 加减联合尼可地尔片治疗。2组均治疗60天。比较2组临床疗效,治疗前后血栓前状态指标[血清血小板α-颗粒 膜蛋白-140(GMP-140)、纤溶酶原激活物抑制剂-1(PAI-1)]、内皮功能指标[血清内皮素-1(ET-1)、一 氧化氮(NO)、内皮细胞特异性分子1(Endocan)] 和心肌损伤因子[血清高敏肌钙蛋白(hs-cTnT)、正五聚 蛋白-3(PTX-3)、淀粉样蛋白A(SAA)],以及不良反应发生率。结果:治疗后,观察组总有效率93.02%(40/43), 高于对照组74.42% (32/43),差异有统计学意义(P<0.05)。2组血清GMP-140、PAI-1、ET-1、Endocan、 hs-cTnT、PTX-3、SAA 水平均较治疗前降低,观察组血清GMP-140、PAI-1、ET-1、Endocan、hs-cTnT、 PTX-3、SAA水平均低于对照组,差异均有统计学意义(P<0.05)。2组血清NO水平均较治疗前升高,观察组 血清NO水平高于对照组,差异均有统计学意义(P<0.05)。观察组不良反应发生率6.98%(3/43),对照组不 良反应发生率11.63%(5/43),2组比较,差异无统计学意义(P>0.05)。结论:血府逐瘀汤加减联合尼可地尔 治疗心血瘀阻型冠心病心绞痛可提高疗效,改善血栓前状态,保护内皮功能,减轻心肌损伤,且安全性良好。

    Abstract:

    Abstract: Objective: To observe the effect of the combination use of modified Xuefu Zhuyu Decoction and Nicorandil on prethrombotic state, endothelial function and myocardial injury of patients with angina pectoris of coronary heart disease of heart blood stasis obstruction type.Methods:A total of 86 patients with angina pectoris of coronary heart disease of heart blood stasis obstruction type admitted to Lanxi Lide Hospital from January 2021 to December 2023 were selected and divided into the observation group and the control group according to the random number table method, with 43 cases in each group. The control group was treated with Nicorandil Tablets, and the observation group was treated with modified Xuefu Zhuyu Decoction with Nicorandil Tablets.Both groups were treated for 60 days. The clinical effects, and prethrombotic state indexes [serum platelet α-granule membrane protein-140 (GMP-140)and plasminogen activator inhibitor-1(PAI-1)],endothelial function indexes [serum endothelin-1(ET-1), nitric oxide(NO), endothelial cell specific molecule 1(Endocan)] and myocardial injury factors [serum highsensitivity cardiac troponin(hs-cTnT),pentraxin-3(PTX-3),serum amyloid A(SAA)] before and after treatment, and the incidence of adverse reactions were compared between the two groups. Results: After treatment, the total effective rate was 93.02%(40/43)in the observation group,higher than that of 74.42%(32/43)in the control group, the difference being significant(P<0.05). The levels of serum GMP-140, PAI-1, ET-1, Endocan, hs-cTnT, PTX-3 and SAA in the two groups were reduced when compared with those before treatment,and the levels of serum GMP-140,PAI-1,ET-1,Endocan,hs-cTnT,PTX-3 and SAA in the observation group were lower than those in the control group,differences being significant(P<0.05).The serum NO levels in the two groups were elevated when compared with those before treatment, and the serum NO level in the observation group was higher than that in the control group,differences being significant(P<0.05).The incidence of adverse reactions was 6.98%(3/43)in the observation group,and 11.63%(5/43)in the control group,there being no significance in the difference(P>0.05). Conclusion:The combination use of modified Xuefu Zhuyu Decoction and Nicorandil can improve the curative effect on angina pectoris of coronary heart disease of heart blood stasis obstruction type,enhance the prethrombotic state and reduce myocardial injury,and protect the endothelial function with good safety.

    参考文献
    相似文献
    引证文献
引用本文

童美姣,童美云,黄建峰.血府逐瘀汤加减联合尼可地尔治疗对冠心病心绞痛患者血栓前状态、内皮功能及心肌损伤的影响[J].新中医,2025,57(18):12-17

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-09-25
  • 出版日期:
文章二维码